HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.

AuthorsJing Feng, Jing Qian, Yanrong Jiang, Mingwei Zhao, Jianhong Liang, Hong Yin, Yi Chen, Wenzhen Yu, Xiaoxin Li
JournalOphthalmology (Ophthalmology) Vol. 124 Issue 3 Pg. 408-409 (03 2017) ISSN: 1549-4713 [Electronic] United States
PMID27914833 (Publication Type: Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Ranibizumab
Topics
  • Angiogenesis Inhibitors (administration & dosage)
  • China
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Intravitreal Injections
  • Male
  • Ranibizumab (administration & dosage)
  • Recurrence
  • Retinopathy of Prematurity (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: